You have 9 free searches left this month | to do more

atezolizumab

Atezolizumab is a drug used to treat Breast Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, and other conditions. Atezolizumab is being actively studied in 313 studies and prior, has been studied in 40.

Top SponsorsTop SitesTop Investigators
Hoffmann-La RocheAsan Medical CenterAslaug Helland
National Cancer Institute (NCI)Seoul National University HospitalDwight Owen
Genentech, Inc.Samsung Medical CenterGulam Manji
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Active, not recruiting
  • Cervical Cancer
  • Leuven, Belgium
    UZLeuven
2021-01-26
Jan 26, 2021
S
Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Atezolizumab
  • Stanford, California
    Stanford University
2021-06-30
Jun 30, 2021
W
Not yet recruiting
  • Stage II Melanoma
  • Atezolizumab
  • +2 more
  • Duarte, California
  • +5 more
2021-09-16
Sep 16, 2021
D
Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-09-20
Sep 20, 2021
U
Not yet recruiting
  • Squamous Cell Carcinoma
  • Urinary Tract Cancer
  • Atezolizumab
  • (no location specified)
2021-09-07
Sep 7, 2021
T
Recruiting
  • Rectal Cancer
  • Amsterdam, Noord-Holland, Netherlands
    Marieke van de Belt
2021-04-19
Apr 19, 2021
M
Not yet recruiting
  • Solid Tumor
  • Atezolizumab
  • +3 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
2021-07-30
Jul 30, 2021
U
Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Essen, Germany
    University Hospital Essen
2021-10-06
Oct 6, 2021
G
Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Washington, District of Columbia
    MedStar Georgetown University Hospital
2021-08-31
Aug 31, 2021
M
Not yet recruiting
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-09
Sep 9, 2021
H
Recruiting
  • Hepatocellular Carcinoma
  • Selinexor Pill
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
2021-10-15
Oct 15, 2021
M
Not yet recruiting
  • Hepatocellular Carcinoma
  • Resectable Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-04-20
Apr 20, 2021
A
Not yet recruiting
  • Colorectal Cancer
  • Atezolizumab
  • (no location specified)
2021-11-02
Nov 2, 2021
T
Recruiting
  • Breast Cancer
  • Amsterdam, Netherlands
  • +3 more
2021-10-18
Oct 18, 2021
I
Recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Thoracic Radiotherapy
  • Atezolizumab
  • thoracic radiotherapy (TRT)
  • Linz, Austria
  • +1 more
2021-08-25
Aug 25, 2021
H
Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
2021-10-04
Oct 4, 2021
U
Recruiting
  • Ovarian Endometrioid Tumor
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-10-21
Oct 21, 2021
D
Recruiting
  • Breast Cancer
  • +3 more
  • Atezolizumab
  • Sacituzumab govitecan
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-10-20
Oct 20, 2021
M
Not yet recruiting
  • Locally Advanced Osteosarcoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-08-18
Aug 18, 2021
W
Recruiting
  • Extensive-stage Small Cell Lung Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-03-25
Mar 25, 2021
U
Not yet recruiting
  • NSCLC Stage IV
  • NSCLC, Recurrent
  • Atezolizumab
  • Fairway, Kansas
  • +1 more
2021-08-24
Aug 24, 2021
G
Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Berlin, Germany
  • +3 more
2021-11-03
Nov 3, 2021
I
Recruiting
  • Solid Tumor
  • +2 more
  • Sutton, Surrey, United Kingdom
    Royal Marsden Hospital NHS Foundation Trust
2021-06-14
Jun 14, 2021